Latest Breaking News On - Centric services for - Page 7 : comparemela.com

France accounts for 3 9% share of global clinical trial activity in 2021

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.

Centric services forLife sciences companiesTranslation services forNervous systemClinical trials databasePharma intelligenceClinical trialsCentric servicesAlternate site clinical trialsLife sciences

Major depressive disorder is a strong risk for future Alzheimer s disease

Major depressive disorder is a strong risk for future Alzheimer s disease
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

United kingdomCentric services forLancet digital healthEu open market solutions for clinical trialsCentric servicesAlternate site clinical trialsPreference management solutionMarket solutions

Renal Cell Carcinoma accounts for 2 5% share of global Oncology clinical trial activity in 2021

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.

United statesUnited kingdomCentric services forTime data services for clinical researchRenal cell carcinomaRenal cellCentral americaClinical trials databasePharma intelligenceClinical trialsTime data servicesClinical researchRegulatory consultationCentric servicesAlternate site clinical trials

Mycobacterium Infections accounts for 1 9% share of global Infectious Disease clinical trial activity in 2021

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.

United statesSouth africaSouth koreaCentric services forTime data services for clinical researchMycobacterium infectionsInfectious diseaseMiddle eastCentral americaClinical trials databasePharma intelligenceClinical trialsTime data servicesClinical researchRegulatory consultationCentric services

Lung Therapeutics concludes Phase Ia trial of Caveolin-1-related peptide

Lung Therapeutics has concluded the Phase Ia trial of its LTI-03 intended for the treatment of idiopathic pulmonary fibrosis (IPF).

New zealandBrian windsorCentric services forSaas platform decentralizing clinical research at scaleLung therapeuticsTaiho pharmaceuticalCentric servicesAlternate site clinical trials